SOURCE: Spencer Pharmaceutical, Inc.

October 11, 2010 09:30 ET

Spencer Pharmaceutical Launches New Corporate Website

BOSTON, MA--(Marketwire - October 11, 2010) -  Spencer Pharmaceutical Inc. (PINKSHEETS: SPPH) announced today the official launch of its website with added investor relations tools.

According to the company, the new website will enable our current shareholder base as well as interested potential shareholders and partners to read comprehensive information on the company, its products, its objectives and achieved milestones. The website can be viewed at

"The re-launch of our website will help our current shareholders and potential ones to keep up to date with all our development," said Dr. Max Arella, President of Spencer Pharmaceutical Inc. "The internet is a very important tool in our corporate communication strategy and the website is a great first step for our company," further added Dr. Arella.

About Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.

Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.

Contact Information

  • Contact:
    Dr. Max Arella
    Spencer Pharmaceutical Inc.
    Tel. 1+(617) 973-5017